D. Robert Dufour, MD
Consultant, Pathology and Hepatology
Veterans Affairs Medical Center and Emeritus Professor of Pathology, George Washington University, Washington, DC

Nathan Clement, MD, Capt MC USAF
Pathology Resident
Department of Pathology, Lackland Air Force Base, San Antonio, Texas

Upon completion of this activity, you will be able to:

• describe the various clinical outcomes that follow acute exposure to hepatitis B virus (HBV).
• differentiate serologic patterns associated with different categories of hepatitis B infection.
• discuss the impact of chemotherapy and immunosuppression on HBV expression.
• compare the similarities and differences between seroreversion and reactivation of hepatitis B.
• develop appropriate testing algorithms to detect persons at risk for HBV reactivation/seroreversion.